1. Abe M, Shiosaki K, Hammar L et al (2006) Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines. Virus Res 121(2):152–160
2. Aihara S, Rao CM, Yu YX et al (1991) Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process. Virus Genes 5(2):95–109
3. Ando K, Satterwhite JP (1956) Evaluation of Japanese B encephalitis vaccine. III. Okayama field trial, 1946–1949. Am J Hyg 63:230–237
4. Ao J, Yu YX, Wu HY et al (1983) Selection of a better immunogenic and highly attenuated live vaccine virus strain of Japanese encephalitis: II. Safety and immunogenicity of live Japanese encephalitis vaccine “SA 14–14–2” observed in inoculated children. Chin J Microbiol Immunol 3:245–248
5. Arroyo J, Guirakhoo F, Fenner S et al (2001) Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol 75(2):934–942